Then, both KEGG and GO analyses revealed that these DEGs induced by DHA treatment were predominantly enriched in the cell cycle pathway, including CDK1, CCNB1, and PLK1 (Figures 4B, C), which has been shown to be associated with the tumor progression and therapeutic results (26, 27). The gene discussed is PLK1; the disease is neoplasm.